Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?

Lancet Oncol. 2007 Mar;8(3):189-90. doi: 10.1016/S1470-2045(07)70053-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Esophageal Neoplasms / therapy*
  • Humans
  • Neoadjuvant Therapy*